⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for The Swedish Study of Liver Transplantation for Non-resectable Colorectal Cancer Metastases

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: The Swedish Study of Liver Transplantation for Non-resectable Colorectal Cancer Metastases

Official Title: A Randomized Controlled, Open-label, Multicentre Study Evaluating if Liver Transplantation With Liver Grafts From Extended Criteria Donors Not Utilised for Approved Indications Increases Overall Survival in Patients With Non-resectable Isolated Liver Metastases From Colorectal Metastases, in Comparison With Best Alternative Care

Study ID: NCT04161092

Study Description

Brief Summary: To evaluate if the addition of liver transplantation primarily utilizing liver grafts from extended criteria donors not utilized for approved indications to conventional treatment of non-resectable/ non-abatable colorectal liver metastases (CLM) increases overall survival compared to best alternative care.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Transplant Institute, Sahlgrenska University Hospital, Gothenburg, , Sweden

Transplantation Unit, Karolinska University Hospital, Stockholm, , Sweden

Contact Details

Name: Per G Lindner, MD, PhD

Affiliation: Transplant Institute, Sahlgrenska University Hospital

Role: PRINCIPAL_INVESTIGATOR

Name: Carl Jorns, MD, PhD

Affiliation: Transplantation Unit, Karolinska University Hospital

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: